<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01271231</url>
  </required_header>
  <id_info>
    <org_study_id>020-2009</org_study_id>
    <nct_id>NCT01271231</nct_id>
  </id_info>
  <brief_title>Study on Periodontal Treatment in Diabetic Patients</brief_title>
  <official_title>Effects of Periodontal Treatment on Clinical Parameters and Glucose Metabolism in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Antioquia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Antioquia</source>
  <brief_summary>
    <textblock>
      Diabetes is a metabolic disorder that affects the uptake of glucose into cells. This causes a
      cascade of systemic alterations that may lead to kidney failure, cardiovascular
      complications, altered tissue healing, retinopathies and gangrene. Diabetes is also
      associated to increased susceptibility to infections and inflammation.

      It has been observed that diabetic patients suffer more often from oral infections such as
      periodontal disease. Periodontal disease is an infectious-inflammatory disease that leads to
      destruction of the surrounding tissues of the tooth. It is proposed that the mechanisms
      responsible for systemic complication are implicated in the development of periodontal
      disease. This has been evaluated in studies where diabetic patients showed increased levels
      of inflammatory cytokines, subgingival bacteria and limited response to treatment. Its has
      also been suggested that established periodontitis in the diabetic patient leads to insulin
      resistance due to infection and liberation of cytokines from periodontal tissues and thus
      worsening the diabetic condition.

      This study is aimed to establish the response to periodontal treatment with antibiotics and
      the kinetics of glucose levels in diabetic patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>1 year</time_frame>
    <description>A sign of gingival inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemia</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Diabetes</condition>
  <condition>Gingivitis</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Group IP1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IP2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IP3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Scaling and root planing plus placebo</intervention_name>
    <description>Single session of scaling and root planing using ultrasonic device. placebo tablets 500 mg, 1 tablet every 24 hours for 3 days</description>
    <arm_group_label>Group IP1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Scaling and root planing plus azythromycin</intervention_name>
    <description>Single session of scaling and root planing using ultrasonic device. Azythromycin tablets 500mg. 1 tablet every 24 hours for 3 days.</description>
    <arm_group_label>Group IP2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prophylaxis plus azythromycin</intervention_name>
    <description>Dental polishing using prophylaxis paste and rubber cups. Azythromycin tablets 500mg. 1 tablet every 24 hours for 3 days.</description>
    <arm_group_label>Group IP3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be of legal age (≥18 years old).

          -  Voluntary participation and signed informed consent.

          -  Confirmed type I and II diabetes.

          -  At least 10 teeth present in mouth.

        Exclusion Criteria:

          -  Smokers.

          -  pregnant women.

          -  Antibiotic consumption 3 months before inclusion.

          -  HIV positive or AIDS.

          -  Allergic reactions to macrolides and specifically to azythromycin.

          -  Periodontal treatment 6 months before inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier E Botero, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad de Antioquia, School of dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fanny L Yepes, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Antioquia, School of dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad de Antioquia, School of dentistry</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol. 2007 Feb 19;99(4A):15B-26B. Epub 2006 Dec 27. Review.</citation>
    <PMID>17307055</PMID>
  </reference>
  <reference>
    <citation>Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991 Feb;62(2):123-31.</citation>
    <PMID>2027060</PMID>
  </reference>
  <reference>
    <citation>Novak MJ, Potter RM, Blodgett J, Ebersole JL. Periodontal disease in Hispanic Americans with type 2 diabetes. J Periodontol. 2008 Apr;79(4):629-36. doi: 10.1902/jop.2008.070442 .</citation>
    <PMID>18380555</PMID>
  </reference>
  <reference>
    <citation>Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):135-41. doi: 10.1097/MED.0b013e3282f824b7. Review.</citation>
    <PMID>18316948</PMID>
  </reference>
  <reference>
    <citation>Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2003 Oct;134 Spec No:34S-40S. Review.</citation>
    <PMID>18196671</PMID>
  </reference>
  <reference>
    <citation>Sammalkorpi K. Glucose intolerance in acute infections. J Intern Med. 1989 Jan;225(1):15-9.</citation>
    <PMID>2645379</PMID>
  </reference>
  <reference>
    <citation>Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996 Oct;67(10 Suppl):1085-93.</citation>
    <PMID>8910827</PMID>
  </reference>
  <reference>
    <citation>Garcia R. Periodontal treatment could improve glycaemic control in diabetic patients. Evid Based Dent. 2009;10(1):20-1. doi: 10.1038/sj.ebd.6400633.</citation>
    <PMID>19322226</PMID>
  </reference>
  <reference>
    <citation>Dağ A, Firat ET, Arikan S, Kadiroğlu AK, Kaplan A. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Aust Dent J. 2009 Mar;54(1):17-22. doi: 10.1111/j.1834-7819.2008.01083.x.</citation>
    <PMID>19228128</PMID>
  </reference>
  <reference>
    <citation>Madden TE, Herriges B, Boyd LD, Laughlin G, Chiodo G, Rosenstein D. Alterations in HbA1c following minimal or enhanced non-surgical, non-antibiotic treatment of gingivitis or mild periodontitis in type 2 diabetic patients: a pilot trial. J Contemp Dent Pract. 2008 Jul 1;9(5):9-16.</citation>
    <PMID>18633464</PMID>
  </reference>
  <reference>
    <citation>Ernst EJ, Klepser ME, Klepser TB, Nightingale CH, Hunsicker LG. Comparison of the serum and intracellular pharmacokinetics of azithromycin in healthy and diabetic volunteers. Pharmacotherapy. 2000 Jun;20(6):657-61.</citation>
    <PMID>10853621</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2011</study_first_submitted>
  <study_first_submitted_qc>January 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2011</study_first_posted>
  <last_update_submitted>May 28, 2013</last_update_submitted>
  <last_update_submitted_qc>May 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Antioquia</investigator_affiliation>
    <investigator_full_name>Javier Enrique Botero</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>periodontal treatment, diabetes, glycemia, glycated hemoglobin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

